share_log

Shareholder Alert: Ademi LLP Investigates Whether Taro Pharmaceutical Industries Limited Has Obtained a Fair Price for Its Public Shareholders in Its Transaction With Its Majority Shareholder, Sun Pharmaceutical Industries Limited.

Shareholder Alert: Ademi LLP Investigates Whether Taro Pharmaceutical Industries Limited Has Obtained a Fair Price for Its Public Shareholders in Its Transaction With Its Majority Shareholder, Sun Pharmaceutical Industries Limited.

股东提醒:Ademi LLP正在调查太郎制药工业有限公司在与其大股东太阳制药工业有限公司的交易中是否为其公众股东获得了公平的价格。
PR Newswire ·  05/20 12:10

MILWAUKEE, May 20, 2024 /PRNewswire/ -- Ademi LLP is investigating Taro (NYSE: TARO) for possible breaches of fiduciary duty and other violations of law in its transaction with its majority shareholder Sun.

密尔沃基,2024年5月20日 /PRNewswire/ — Ademi LLP正在调查Taro(纽约证券交易所代码:TARO)在与大股东太阳的交易中可能违反信托义务和其他违法行为

Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

点击此处了解如何加入或拨打 Guri Ademi 的免费电话 866-264-3995。您无需支付任何费用或承担任何义务。

In the transaction, Taro's stockholders receive $43.00 in cash for each share of Taro common stock they own. Taro insiders receive substantial benefits as part of change of control arrangements and Taro's board is not likely to have been independent in its negotiation of the transaction given Sun's majority position.

在交易中,Taro的股东每持有Taro普通股可获得43.00美元的现金。作为控制权变更安排的一部分,太郎内部人士获得了可观的收益,鉴于孙的多数地位,太郎董事会在交易谈判中不太可能保持独立。

We are investigating the conduct of Taro's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

我们正在调查太郎董事会的行为,以及他们是否履行了对所有股东的信托责任。

If you own Taro common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or

如果你拥有太郎普通股并希望获得更多信息,请致电 [email protected] 或免费电话:866-264-3995 与 Guri Ademi 联系,或

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我们专门处理涉及收购、合并和全国各地个人股东权利的股东诉讼。欲了解更多信息,请随时致电我们。律师广告。先前的结果并不能保证类似的结果。

Contacts

联系人

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Ademi LLP
Guri Ademi
免费电话:(866) 264-3995
传真:(414) 482-8001

SOURCE Ademi LLP

来源 Ademi LLP

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发